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Abstract
Serotonin (5-hydroxytryptamine: 5-HT) affects numerous functions in the gut, such as secretion, muscle contraction, and
enteric nervous activity, and therefore to clarify details of 5-HT’s actions leads to good therapeutic strategies for gut
functional disorders. The role of interstitial cells of Cajal (ICC), as pacemaker cells, has been recognised relatively recently. We
thus investigated 5-HT actions on ICC pacemaker activity. Muscle preparations with myenteric plexus were isolated from the
murine ileum. Spatio-temporal measurements of intracellular Ca
2+ and electric activities in ICC were performed by
employing fluorescent Ca
2+ imaging and microelectrode array (MEA) systems, respectively. Dihydropyridine (DHP) Ca
2+
antagonists and tetrodotoxin (TTX) were applied to suppress smooth muscle and nerve activities, respectively. 5-HT
significantly enhanced spontaneous Ca
2+ oscillations that are considered to underlie electric pacemaker activity in ICC. LY-
278584, a 5-HT3 receptor antagonist suppressed spontaneous Ca
2+ activity in ICC, while 2-methylserotonin (2-Me-5-HT), a 5-
HT3 receptor agonist, restored it. GR113808, a selective antagonist for 5-HT4, and O-methyl-5-HT (O-Me-5-HT), a non-
selective 5-HT receptor agonist lacking affinity for 5-HT3 receptors, had little effect on ICC Ca
2+ activity. In MEA
measurements of ICC electric activity, 5-HT and 2-Me-5-HT caused excitatory effects. RT-PCR and immunostaining confirmed
expression of 5-HT3 receptors in ICC. The results indicate that 5-HT augments ICC pacemaker activity via 5-HT3 receptors. ICC
appear to be a promising target for treatment of functional motility disorders of the gut, for example, irritable bowel
syndrome.
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Introduction
Special interstitial cells with abundant c-Kit receptors on their
surface are distributed throughout the gastrointestinal tract. These
cells are referred to as interstitial cells of Cajal (ICC) due to the
histological features of the network [1–3]. It is now considered that
ICC in the myenteric region act as pacemaker cells, and produce
gut movements in concert with enteric neurones and smooth
muscle cells [4–6]. Numerous neurotransmitters and hormones are
likely to affect ICC activity, and thereby modulate gut motility.
Serotonin (5-hydroxytryptamine: 5-HT), well known for mood
control in the brain, also plays a crucial role in cellular signalling in
the gut. Indeed, enterochromaffin cells release the majority
(.90%) of 5-HT in the human body in response to the pressure
of intraluminal content and other noxious stimuli [7]. Some
enteric neurones in the descending peristaltic reflex pathway also
release 5-HT as a neurotransmitter [8–10]. Since enteric neurones
and smooth muscle cells express various 5-HT receptors
depending upon cell type and location of the cell, and their
functions are critically affected by this signalling molecule [11,12],
5-HT receptors are key targets in pharmacological interventions of
gut functional disorders, as well as psychiatric disorders of the
brain.
It is thought that oscillations of the intracellular (cytosolic) Ca
2+
concentration ([Ca
2+]i) in ICC cells underlie gut pacemaker
activity. Namely, periodic activation of Ca
2+-sensitive ion channels
in the plasma membrane generates pacemaker potentials [13,14].
Previously, we demonstrated that spontaneous electrical activity
occurs in synchrony with [Ca
2+]i oscillations in ICC, and that
coordinated actions of intracellular Ca
2+ release channels and
transmembrane Ca
2+ influx pathways underlie ICC [Ca
2+]i
oscillations [15–17].
In the present study, we provide evidence that 5-HT regulates
ICC pacemaker activity. We performed Ca
2+ imaging and
potential mapping of ICC pacemaker activity using fluorescent
Ca
2+ probes and microelectrode array (MEA), respectively, and
found that 5-HT enhances both Ca
2+ and electric activities of ICC
via 5-HT3 receptors, which are nonselective cation channels
permeable to Ca
2+. We also carried out RT-PCR and immuno-
staining to confirm the expression of 5-HT3 receptors in ICC. Our
findings suggest that 5-HT modulation of ICC activity should also
be considered for gut motility disorders, for example, irritable
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Interestingly, this disease is known to be frequently complicated
by psychiatric illness and mood disorders.
Materials and Methods
Animals
Animals used in the present study were treated ethically. All
procedures were approved by the Institutional Animal Care and
Use Committee. BALB/c (wild-type) and W/W
v mice (3–6 weeks
after birth) were killed by cervical dislocation, after being
anaesthetized with diethyl ether. Unless otherwise stated, BALB/
c mice were used in all experiments.
Ca
2+ imaging
Cell cluster preparations were used in Ca
2+ imaging [16,19].
Although we detected 5-HT-augmentation of ICC Ca
2+ activity in
isolated ileal musculature segments containing the myenteric
plexus (Figure S1; Video S1 and Video S2), we used cell cluster
preparations in Ca
2+ imaging to examine numerous drugs related
to 5-HT, because it was difficult to stably load Ca
2+ indicators in
many intact muscle segments.
The musculature along with the myenteric plexus were carefully
dissected from the ileum, and incubated in Ca
2+-free Hanks’
solution containing collagenase (1 mg/ml, Wako Chemical,
Osaka, Japan), trypsin inhibitor (2 mg/ml, type I-S, Sigma, St
Louis, MO, USA), ATP (0.3 mg/ml, Seikagakukogyo, Tokyo,
Japan), and bovine serum albumin (2 mg/ml, Sigma) for 40 min
at 37uC. The musculature preparation was then triturated with
fire-blunted glass pipettes. The resultant cell clusters were plated
onto a lab-made culture dish, and kept in Dulbecco’s modified
Eagle’s medium (Sigma) supplemented with 10% foetal bovine
serum (Sigma) and antibiotics (30 mg/ml streptomycin and
30 units/ml penicillin; Sigma) at 37uC for 2–3 days.
The cultured cell cluster preparations were incubated in ‘normal’
solution containing approximately 8 mM Fluo3-AM (acetoxymethly
ester of Fluo-3: Dojindo, Kumamoto, Japan) and detergents (0.02%
Pluronic F-127: Dojindo; 0.02% cremophor EL, Sigma) for 3–4 h
at room temperature. A CCD camera system (Argus HiSCA,
Hamamatsu Photonics, Hamamatsu, Japan) was used to continu-
ously monitor digital images of Fluo-3 emission light. The cell
clusters were illuminated at 488 nm and emission light of 515–
565 nm was detected. The temperature of the recording chamber
was kept at 35uC using a micro-warm plate system (MP10DM,
Kitazato Supply, Fujinomiya, Japan). Digital images (0.963 mm/
pixel) were normally collected at 300 ms intervals. Changes in
fluorescenceemissionintensity(F)were expressedasFt/F0,whereF0
is the basalfluorescenceintensity.Ratio-imageswereconstructedby
dividing each Ca
2+ image with a Ca
2+ image acquired at a basal
[Ca
2+]i time after subtracting background fluorescence. The
frequency of spontaneous [Ca
2+]i oscillations in the presence of
nifeipine (and TTX) did not differ from that of spontaneous
oscillatory inward currents previously measured by the patch clamp
technique [20]. We thus judged that the procedure for loading fluo-
3 was appropriate, and the spontaneous [Ca
2+]i activity reflected
pacemaker activity in ICC. This notion also agrees well with
previous reports in which dihydropyridine (DHP) Ca
2+ antagonists
selectively suppress [Ca
2+]i activity in smooth muscle by blocking L-
type Ca
2+ channels [13,19].
In preliminary experiments, we checked the effects of several
concentrations of 5-HT receptor agonists and antagonists in order
to assess which subtypes of 5-HT receptors are responsible for the
augmentation of [Ca
2+]i oscillations in ICC. First, 5-HT was
examined at 1, 3, 10 and 50 mM (n=3–4). The active area of
[Ca
2+]i oscillations was nearly the same (102% of the control) at 1–
3 mM, and increased to ,145% at 10 mM and to ,149% at
50 mM. We thus compared the effects of 5-HT and other 5-HT
receptor agonists at 10 mM (Fig. 1 and 2). LY-278584, a 5-HT3
antagonist, did not significantly suppress [Ca
2+]i oscillations below
10 mM in 10 min. In order to minimize the deterioration of fluo-3
fluorescence during illumination, 10 mM of LY-278584 was
normally applied (Fig. 2A–B). Also, according to previous
experiments in enteric neurones and ICC, 10 mM GR113808
[21] and 40 mM SK&F96365 [17] were used to inhibit 5-HT4
receptors and Ca
2+-permeable transmembrane channels, respec-
tively (Fig. 2C–D).
Electrical recording
An 868 planar microelectrode array (150 mm in polar distance)
connected to a 64-channel amplifier (MED 64 System: Alpha Med
Science, Osaka, Japan) was used to simultaneously record electrical
field potentials of ,1m m
2 square [22,23]. Ileal musculature
segments (,5m m 620 mm) containing the myenteric plexus were
fixed using a brain slice anchor (SDH series, Harvard Apparatus
Japan, Tokyo, Japan) in the recording chamber kept at 35uCo na
heater, and were superfused with ‘normal’ extracellular solution at a
constant rate of 2 ml/min. The extracellular solution contained
nifedipine (Sigma) and TTX (LKT Laboratories: St Paul, MN,
USA) in order to isolate ICC pacemaker activity by suppressing
smooth muscle and neural activities. Slow electrical potentials were
recorded by applying a high-pass filter of 0.1 Hz to stabilize the
baseline drift [24]. A sampling rate of 20 kHz was applied.
In fieldpotential data processing, the digital resolution was reduced
to 50 ms (20 Hz) by thinning out the recording points at 1:1000, and
an FFT-based digital band-pass filter (0.04–0.5 Hz) was additionally
applied. The effects of 5-HT and 2-Me-5-HT on ICC pacemaker
electrical activity were evaluated using a power spectrum (9.4–
27.0 cpm). Two-dimensional field potential images were constructed
by calculating the values at the desired location via spline
interpolation (with 50 points between each electrode), using the
MATLAB software package (Mathworks: Natick, MA, USA) [25].
RT-PCR
A longer (50 min) enzymatic incubation and more complete
trituration with glass pipettes were performed to obtain isolated
cells. The digestive enzymes used were the same as described for
cell cluster preparations. The resultant cell suspension was
incubated in a ‘normal’ extracellular solution containing phyco-
erythrin-conjugated anti-mouse CD117 (c-Kit) antibody (PE-
ACK2, eBioscience, San Diego, CA, USA) in 1/100 v/v for
10 min, and then centrifuged and rinsed with ‘normal’ solution
three times. About 5–10 isolated smooth muscle cells and c-Kit-
immunopositive cells were separately collected into sterile tubes,
using patch pipettes (GC150-15, Harvard Apparatus, Kent, U.K.)
with 10–20 mm tip diameter under a fluorescent microscope. The
samples were kept at 280uC until use. The procedures for
subsequent RT-PCR were the essentially the same as previously
described [26].
The following PCR primers were used: 5-HT2B (NM_008311,
1340-1443, amplicon =104 bp): 59-GATCAACCCTGCCATG-
TACCA-39 (+) and 59-CGCCATCGTTTTCAGTGAGA-39 (-);
5-HT3A (NM_013561, 363-463, amplicon =101 bp): 59-GAC-
TCCTGAGGACTTCGACAATG-39 (+) and 59-ACTTCCC-
CACGTCCACAAACT-39 (-); 5-HT3B (NM_020274, 607-728,
amplicon =122 bp): 59-ACTCTTCTGGCACCATTAGAACC-
39 (+) and 59-GAGGCTGCAGTTCTGGATATCA-39 (-); 5-HT4
(NM_008313, 1100-1222, amplicon =123 bp): 59-CTTTCC-
TCTGGCTTGGCTATATCA-39 (+) and 59-GTCTTTTGT-
Serotonin Augments Gut Pacemaker Activity
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24928AGCGCTCATCATCAC-39 (-); c-Kit (Y00864, 2156-2256,
amplicon =101 bp): 59-GAGCCTTCCTGTGACAGTTCAAA-
T-39 (+) and 59-TCTATTCTTGCGGATCTCCTCTTG-39 (-);
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) (M32599,
730–833, amplicon =104 bp): 59-CATGGCCTTCCGTGT-
TCCT-39 (+) and 59-CCTGCTTCACCACCTTCTTGA-39 (-);
CD68 (a marker for mast cells) (NM_009853, 574-830, amplicon
=257 bp): 59-CACCTGTCTCTCTCATTTCC-39(+) and 59-
CTTAGAGAGAGCAGGTGAAG-39 (-); Cma1 (a marker for
macrophages) (NM_010780, 332–668, amplicon =337 bp): 59-
CGGGAAGGTCTATAACAGTCCTCC-39 (+) and 59-CTGG-
TGAAGTGTTTGCAGGCT-39(-). The pair of primers for 5-
HT4 was also designed to cover 5-HT4A, 5-HT4B, 5-HT4E, and 5-
HT4F.
Immunohistochemistry
Small segments (10 mm620 mm) of smooth muscle layers
(including the myenteric plexus) isolated from the mouse ileum,
were fixed with 4% paraformaldehyde (4uC) for 30 min, and
permeabilized with 0.1% triton X-100 and 5% BSA (bovine serum
albumin, fraction V: Sigma) for 1 h. The tissue was double stained
sequentially with anti-5-HT3 antibody [SR-3 (H-138) sc-28958:
Santa Cruz Biotechnology, Santa Cruz, CA, USA] and anti-
mouse CD117 (c-Kit) antibody (ACK4: Acris antibodies, Ger-
many) in 100 mM PBS (phosphate buffered-saline solution)
overnight. The PBS contained 1% BSA in order to block non-
specific reactions. This was followed by incubation with secondary
antibodies, Alexa Fluor 488-conjugated anti-rabbit IgG and Alexa
Fluor 555-conjugated anti-rat IgG (Molecular Probes, Eugene,
OR, USA) at a concentration of 15 mg/ml for 1 h. Double-stained
small segments were mounted on a slide glass with an anti-fading
agent (ProLong: Molecular Probes) and scanned using a confocal
microscope (TCS-SP2: Leica Microsystems, Tokyo, Japan).
Controls were prepared by omitting the primary antibodies. The
reactivity was negligible in network-forming cells in the myenteric
plexus (i.e. ICC). The antibody used for staining the 5-HT3
receptor (sc-28958: Santa Cruz Biotechnology) is a rabbit
polyclonal antibody raised against amino acids 341–478 mapping
at the C-terminus of 5-HT3A of human origin, and is used in
human, mouse and rat specimens.
Solutions and drugs
The composition of the ‘normal’ extracellular solution used in
[Ca
2+]i imaging and electrical recording was (in mM): NaCl, 125;
KCl, 5.9; MgCl2 1.2; CaCl2 2.4; glucose 11; Tris-HEPES 11.8
(pH 7.4). Nifedipine, LY-278584, 2-methyl-5-HT (maleate salt),
GR113808 and O-methyl-5-HT (hydrochloride) were purchased
from Sigma. SK&F96365 was from Calbiochem (San Diego, CA,
U.S.A.). Stock solutions of nifedipine were prepared by dissolving
the drug in ethanol, while other drugs were dissolved in dimethyl
sulfoxide (DMSO). The working concentrations of the solvents
were less than 1%. In preliminary experiments, we observed that
applications of this concentration of either solvent alone had little
effect on [Ca
2+]i oscillation in cell cluster preparations. DMEM
and other reagents for cell culture were purchased from Sigma.
Statistics
Numerical data are expressed as mean6SD. Differences
between means were evaluated by paired t-tests. The probability
(P),0.05 was taken as a statistically significant difference.
Figure 1. 5-HT potentiates ICC pacemaker [Ca
2+]i activity. A) Ca
2+ images acquired from a cell cluster preparation in control (a-b) and 5 min
after 5-HT (10 mM) application (c-d). B) Time course of pacemaker [Ca
2+]i activity recorded in the three squares (x, y and z) indicated in Ba. Dotted lines
correspond to the times when images (Ba-d) were acquired. Changes in fluorescence emission intensity (F) are expressed as Ft/F0, where F0 is the
basal fluorescence intensity. C-E) Bars show changes in the peak amplitude (C), frequency (D), and active area of spontaneous pacemaker [Ca
2+]i
activity (E) (Mean 6 s.d., n=22). Asterisks, P,0.05 compared to control. F-G) Immunohistochemistry of the ileal myentric plexus (MyP) layer in wild-
type (F) and W/W
v mice (G) lacking ICC in this region of the small intestine. Red and green represent neurones (PGP9.5) and ICC (c-Kit), respectively. H)
The lack of effect of 5-HT (10 mM) in a cell cluster preparation from W/W
v mice.
doi:10.1371/journal.pone.0024928.g001
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5-HT augments [Ca
2+]i activity in ICC
ICC generate pacemaker activity employing [Ca
2+]i oscillations
[13,14]. To examine the effect of 5-HT on [Ca
2+]i activity in ICC,
we used cell cluster preparations (100–200 mm in diameter)
obtained from the mouse ileum. This preparation contains ICC,
smooth muscle cells and enteric neurons, and is considered to be
an integrated model system to investigate gut pacemaker activity.
Dihydropyridine (DHP) Ca
2+ antagonists can selectively suppress
[Ca
2+]i and contractile activities of smooth muscle cells by
blocking L-type Ca
2+ channels, while pacemaking [Ca
2+]i
Figure 2. Evidence that endogenous 5-HT generates basal pacemaker [Ca
2+]i activity via 5-HT3. A-D) Examples of effects of drugs relating
to 5-HT. Each time course of changes in [Ca
2+]i activity was acquired 3–5 min after application of drugs. All measurements were carried out in the
presence of 1 mM nifedipine. LY-278584, 2-Me-5-HT, GR113808 and O-Me-5-HT were applied at 10 mM, and SK&F96365 was applied at 40 mM. E)
Graphs summarizing the effects of drugs relating to 5-HT on the amplitude of pacemaker [Ca
2+]i oscillations. Blue bar represents the control. Blue and
red bars in the left graph include both experiments (n=10) for control and subsequent application of LY-278584 shown in A (n=5) and B (n=5).
Statistical significance of the effects of 2-Me-5-HT and O-Me-5-HT were evaluated by comparing with each control observed in the presence of LY-
278584 (n=5, each). Middle and right graphs represent experiments shown in C (n=5) and D (n=5), respectively. Asterisks (P,0.05). n.d. (No [Ca
2+]i
activity detected.).
doi:10.1371/journal.pone.0024928.g002
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2+]i
imaging in the presence of nifedipine.
A typical effect of 5-HT is shown in Fig. 1A. In the continuous
presence of nifedipine (1 mM), spontaneous [Ca
2+]i oscillations
were observed in a small limited area (near (x)) [control: Panels (a–
b) in Fig. 1A]. Application of 5-HT (10 mM) enlarged the region
showing spontaneous [Ca
2+]i oscillations [Panels (c–d)]. The time
course of changes in [Ca
2+]i (Ft/F0) is plotted in Fig. 1B. In control
conditions (a), only the region of interest (ROI) (x) shows [Ca
2+]i
oscillations with an amplitude of more than 1.2 (Ft/F0), while such
activity was negligible in ROI (y) and (z). After application of 5-
HT, the area yielding spontaneous [Ca
2+]i oscillations enlarged,
covering all three regions (x–z) synchronously. The peak amplitude
in ROI (y) reached 80–90% of that in (x). On average, the area
yielding [Ca
2+]i oscillations increased from 11.566.0 to
42.5618.3% (n=22), while the frequency was little affected
(19.461.2 in normal vs. 19.561.7 cycles/min in the presence of 5-
HT, n=22) (Fig. 1C–E). Essentially similar effects of 5-HT were
observed even in the presence of TTX as well as nifedipine (n=5),
suggesting that 5-HT augmented ICC pacemaker activity, but not
through neural activity.
An interesting response was observed in preparations showing
intermittent [Ca
2+]i oscillations. 5-HT (10 mM) caused the activity
towards a continuous oscillation pattern, with a significant
enlargement of the oscillation active area (n=6) (Figure S2).
When [Ca
2+]i imaging was carried out in ileal cell cluster
preparations from W/W
v mice, which have few pacemaking
interstitial cells in this part of the small intestine (Fig. 1F–G) [27–
29], no [Ca
2+]i oscillation was observed irrespective of 5-HT
application (in the presence of 1 mM nifedipine, n=4) (Fig. 1H).
This result confirms that ICC are responsible for 5-HT-mediated
enhancement in normal mice.
5-HT receptor agonists and antagonists
Next, we assessed which receptors are responsible for 5-HT-
mediated pacemaker [Ca
2+]i activity. In these experiments, we
used preparations showing synchronous [Ca
2+]i oscillations (like
the preparation shown in Fig. 1). Application of LY-278584
(10 mM), an antagonist for type 3 5-HT receptors (5-HT3)
significantly decreased the amplitude of the oscillations, and the
intervals between them often became irregular (middle traces in
Fig. 2A–B). Almost complete recovery was achieved by additional
application of 10 mM 2-methyl-5-HT (2-Me-5-HT), a selective
agonist for 5-HT3 receptors (Fpeak/F0: 1.2760.06 in control vs
1.2560.06 with 2-Me-5-HT, n=5) (the right trace in Fig. 2A).
Also, in order to confirm the target cells, 2-Me-5-HT (10 mM) was
applied in cell cluster preparations from W/W
v mice, but no
[Ca
2+]i oscillation was induced (n=5).
O-methyl-5-HT (O-Me-5-HT) is a known non-selective 5-HT
receptor agonist, but lacking affinity for 5-HT3 receptors.
Application of O-Me-5-HT (10 mM) caused no recovery of
spontaneous [Ca
2+]i activity in the presence of LY-278584
(10 mM)(n=4, Fig. 2B). Essentially the same results as shown in
Fig 2A–B were obtained in the presence of TTX (250 nM),
indicating that there is no contribution of neural activity: Namely
these drugs work through action potential-independent mecha-
nisms.
In contrast to the effects of 5-HT3 antagonists, application of
10 mM GR113808, a selective antagonist for 5-HT4, had little
effect on spontaneous [Ca
2+]i oscillations in ICC (Fpeak/F0:
1.2560.06 in control vs 1.2260.02, n=5)(middle trace in
Fig. 2C). Additional application of 10 mM LY-278584 again
suppressed [Ca
2+]i activity (right trace in Fig. 2C). These
pharmacological examinations, together suggest that pacemaker
[Ca
2+]i activity in ICC is generated by endogenous 5-HT via 5-
HT3 receptors.
Ca
2+ influx sensitive to SK&F96365 plays an essential role in
generating ICC pacemaker [Ca
2+]i activity, presumably co-
ordinating with intracellular Ca
2+ release channels [16,17]. In
order to assess whether this Ca
2+ influx pathway contributes to the
pacemaker activity mediated via 5-HT3 receptors, the effect of 2-
Me-5-HT was examined in the presence of SK&F96365.
Application of 40 mM SK&F96365 suppressed pacemaker
[Ca
2+]i activity in ICC as observed previously [17], but subsequent
Figure 3. RT-PCR examinations for 5-HT receptors. A) RNA
samples were obtained from isolated c-KIT-immunopositive cells (ICCs)
or smooth muscle cells (SMC). NTC represents ‘no template control’. RT-
PCR was performed for 5-HT2B, 5-HT3A, c-kit and GAPDH (an index of
proper amplification). Numbers on the right of each gel indicate the size
marker (bp). B) Examples of RT-PCR detection of mast cell markers
(CD68 and Cma1) in spleen (35 cycles) and c-kit-immuopositive cells (50
cycles).
doi:10.1371/journal.pone.0024928.g003
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The responses of pacemaker [Ca
2+]i activity to the drugs relating
to 5-HT receptors and Ca
2+ influx are summarized in Fig. 2E.
5-HT3 receptors in ICC
To confirm expression of 5-HT receptors in ileal ICC, we
performed RT-PCR. After enzymatic dispersion, c-Kit immuno-
positive interstitial cells (equivalent to ICC) and smooth muscle
cells were individually collected. A transcript for 5-HT3A was
detected only in ICC, while 5-HT2B was detected in both ICC and
smooth muscle cells (Fig. 3A). We also confirmed that neither
CD68 nor Cma1 (mast cell markers) was detected in c-Kit-
immunopositive interstitial cells (n=4), unlike in spleen samples
(n=4) (Fig. 3B). In addition, transcripts for 5-HT3B and 5-HT4
were detected in ICC, but not in smooth muscle cells (not shown).
Immunohistochemistry was also performed. Double-labelled
immunostaining with anti-c-Kit and anti-5-HT3 antibodies (Fig. 4)
revealed that network-forming interstitial cells expressing both 5-
HT3 and c-Kit (orange cells in left panel) exist near the myenteric
plexus, which contains neurons with only 5-HT3 immunoreactivity
(green). In addition, these network-forming cells have large nuclei
(a single cell is shown expanded in the right panels). The network-
like structure and large nuclei are known features of ICC [2,6].
Augmentation of electrical activity
In order to confirm the excitatory effect of 5-HT on ICC
pacemaker activity, we next measured electrical activity. Isolated
musclature of the mouse ileum was placed on an 868
microelectrode array (MEA) with a polar distance of 150 mm,
and field potentials of a ,1m m
2 area were simultaneously
monitored through a multi-channel amplifier and recording
system (See Materials and Methods). To suppress smooth muscle
and neural activities, extracellular solution contained nifedipine
(1 mM)) and TTX (250 nM), respectively.
A potential map was constructed by using the simultaneous
recordings at 64 channels and spline interpolation (Fig. 5A–B). In
this preparation, ICC electrical activity propagated from the left
bottom to the right top in normal solution (A), and application of
5-HT (10 mM) potentiated ICC electrical activity (B). Represen-
tative field potentials of three channels (Fig. 5C–D) show ICC
electrical activities for a long duration. 5-HT significantly
increased the amplitude of the field potentials, but did not alter
the frequency (Video S3 and Video S4). Also, power spectra over
the recording area were constructed from field potentials of all 64
channels for approximately 40 s. This analysis shows a marked
increase in the spectral power without shifting the peak frequency.
The effect of 2-Me-5-HT (10 mM), a 5-HT3 receptor agonist
(Figure S3), on ICC electrical activity was also examined.
Essentially similar enhancement was observed. Graphs in Fig. 6
summarise the enhancement of 5-HT and 2-Me-5-HT on ICC
electrical activity. The spectral power between 9.4-27.0 cpm
(Pw9.4-27.0cpm) was used to evaluate the ICC electrical activity,
based on a comparison between wild-type and W/W
v mice [23].
In the control of normal ileum, Pw9.4–27.0cpm (from 64 channels)
ranged from 1.0 to 19.0610
23 mV
2 (n=24). Application of 5-HT
increased Pw9.4–27.0cpm to 168645% (P,0.01, n=12), and 2-Me-
5-HT increased it to 153635% (P,0.01, n=12).
Discussion
ICC act as gut pacemaker cells. Moreover, fairly recent studies
suggest that these cells also coordinate peristaltic movements
through their network-forming structure [30]. In the light of the
important roles of ICC, any hormones and neurotransmitters that
modulate ICC activity are considered to have a significant
influence upon gut motility. The present finding that 5-HT
augments ICC activity implies that this signalling molecule in
particular plays a crucial role in regulating gut motility, because
the gut contains a majority of 5-HT in the body [8,11].
The fact that 2-Me-5-HT causes similar effects to 5-HT implies
that 5-HT3 receptors are responsible for the 5-HT-mediated
enhancement of ICC Ca
2+ activity. Lines of studies have suggested
that the primary pacemaking activity is the spontaneous [Ca
2+]i
oscillations in ICC [13,15,31]. Namely, [Ca
2+]i oscillations in ICC
periodically activate plasmalemmal Ca
2+-activated ion channels:
Ca
2+-activated Cl
2 channels [32–35], and/or Ca
2+-activated non-
selective cation channels [36–38]. Ca
2+ release from the
intracellular Ca
2+ stores, presumably endoplasmic reticulum
(ER), appears to be the major Ca
2+ source of [Ca
2+]i oscillations
Figure 4. Immunohistochemistry for c-KIT and 5-HT3. Smooth muscle layer of the ileum including the myenteric plexus was double-labelled
with anti-c-KIT antibody (ACK4, red) and anti-5-HT3 antibody (sc-28958, green). Left panel (A: merged image) shows myenteric neurons (plexus)
(green) surrounded by network-forming cells expressing both c-KIT and 5-HT3. Bar, 50 mm. An ICC-like cell is shown expanded in right panels (B:
merged image; C: c-KIT; D: 5-HT3). Bar, 10 mm. The network-like structure and large nucleus are known histological features of ICCs.
doi:10.1371/journal.pone.0024928.g004
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2+ influx from the extracellular space is required
to maintain this [Ca
2+]i activity (periodic Ca
2+ release) [13],
although co-ordinating mechanisms for these Ca
2+ pathways are
not yet understood. Since 5-HT3 receptors are ligand-gated non-
selective cation channels, permeable to Ca
2+ [39,40], this channel
is likely to act as a Ca
2+ influx pathway to enhance pacemaker
activity in ICC (Figure S4). This notion is supported by the fact
that SK&F96365, which is known to block a broad range of Ca
2+-
permeable non-selective cation channels [41–43], terminates ICC
pacemaker Ca
2+ activity even in the presence of 2-Me-5-HT
(Fig. 2D). Also, ICC is known to express DHP-insensitive voltage-
gated Ca
2+-permeable channels [44,45]. This transmembrane
Figure 5. MEA measurements of ICC electrical activity in the presence of nifedipine (1 mM) and TTX (250 nM). A-B) Field potential
images constructed at 200 ms. The top and bottom of the images correspond to the oral and anal ends of the preparation, respectively. C-D)
Representative field potential recordings at three channels in the same preparation. The dotted lines indicate the period of the potential images (PI)
acquired. E-F) Power spectra constructed from field potential recordings at all 64 channels. A, C and E: control; B, D and F: during application of 5-HT.
doi:10.1371/journal.pone.0024928.g005
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2+ pathway may simultaneously contribute to the enhancement
of ICC [Ca
2+]i activity.
Five subunits (i.e. 5-HT3A–E) are known to form the 5-HT3
receptor complex, and changes in the composition alter Ca
2+-
permeability of this channel [46]. In future studies, it would be of
interest to elucidate the composition of 5-HT3A-E receptor
subtypes and how 5-HT3 receptors are coupled to Ca
2+ release
channels in intracellular Ca
2+ stores to generate pacemaker
[Ca
2+]i activity. Polymorphism of these 5-HT3 receptor subunit
genes seems likely to affect gut motility by modulating ICC as well
as neuronal activities [12], and underlies some functional disorders
[47]. Furthermore, RT-PCR examinations detected transcripts of
other 5-HT receptor genes in ICC i.e. 5-HT2 and 5-HT4 receptor
genes [48,49]. Recent studies have shown that 5-HT2B receptor
antagonists reduced proliferation of cultured ICC, and that the
small intestine of mice lacking 5-HT2B receptors contains less ICC
in the myenteric and deep muscular plexuses, although intestinal
transit is not significantly slowed [50,51]. On the other hand, 5-
HT4 receptor antagonists impair the regeneration of enteric
neurons after surgical operation and their development in gut-like
organs derived from mouse embryonic stem cells, with indistin-
guishable changes in the ICC network [21,52]. It is likely that 5-
HT causes numerous effects via these different 5-HT receptors,
depending on cell type, location of the gut, and the stage of
development and aging.
The scenario for 5-HT augmentation of ICC activity is possibly
modified by the roles of adjacent cells in the actual gut. In the
present study, we applied nifedipine and TTX to clearly
demonstrate the effect of 5-HT on ICC; however, smooth muscle
cells and enteric neurones suppressed by these inhibitors may also
be involved, because coordinated actions of these cells produce gut
motility [4]. For example, as seen in Fig. 5, ICC pacemaker
activity propagates on the luminal plane. Indeed, electric
conduction of gut pacemaker activity along the musculature can
be detected magnetically [53]. It is thought that ICC and smooth
muscle cells are electrically connected [54]. Therefore, under
normal conditions (without DHP Ca
2+ antagonists), in addition to
network-forming processes in ICC, the smooth muscle bundle
conducts a part of electric current generated by a group of ICC,
and amplifies pacemaker activity in adjacent ICC, because it is
thought that ICC possess a mechanism to transform depolarisation
in the plasma membrane into activation of [Ca
2+]i oscillations for
pacemaking [55,56]. Also, some populations of enteric neurones
may release activators for ICC pacemaker activity in response to
5-HT. In the myenteric plexus, serotonergic neurones are involved
in descending contraction [9,10], and it is known that ICC express
numerous receptors for excitatory neurotransmission, e.g. pur-
inoceptors, neurokinin and acetylcholine receptors [57–60]. These
molecules may access ICC to activate in parallel.
The present finding on augmentation of ICC activity via 5-HT3
receptors implies pharmacological interventions on gut motility
disorders. For example, irritable bowel syndrome, classified into
two types, i.e. diarrhoea- and constipation-dominant IBS (d-IBS
and c-IBS), is known to involve 5-HT-related mechanisms along
with infectious and inflammatory changes. Excess 5-HT due to
impairment of reuptake transport is ascribed to some populations
of d-IBS [61–63]. Also, antineoplastic drugs, e.g. cisplatinum,
stimulate 5-HT release [64–66]. In such cases, it is rational to
suppress ICC pacemaker activity in addition to nervous activities
by blocking 5-HT3 receptors. It is speculated that stimulation of 5-
HT3 receptors in enteric neurons and ICC synergically facilitates
gut contractility and afferent neural activity toward the brain.
Thereby, 5-HT3 receptors in the gut may contribute to the gut-
brain axis. As seen in murine ileal ICC, we have also observed that
5-HT3 receptor agonists potentiate, while antagonists suppress
both Ca
2+ and electric pacemaker activities in the murine stomach
in preliminary experiments. Although extensive studies are
required in model animals and humans, 5-HT is likely to enhance
ICC pacemaker activity throughout the gastrointestinal tract.
Similar regulatory mechanisms may underlie other peripheral
spontaneous activities. Evidence is being accumulated that ICC-
like interstitial cells ubiquitously exist in many organs and tissues
that are effectors of the autonomic nervous system, such as the
ureter, urinary bladder, urethra, uterus, lymph ducts, veins, etc,
suggesting their possible contribution to spontaneous activity [67–
71]. Also, in some ICC-like cells, spontaneous [Ca
2+]i and electric
activities have already been demonstrated. In the light of
regulatory mechanisms of ICC and ICC-like cells, investigating
functional disorders related to a wide range of peripheral
spontaneous rhythmicity, e.g. irritable bladder, is merited.
In summary, the present study has shown 5-HT augmentation
of ICC pacemaker activity via 5-HT3 receptors. Since 5-HT3
receptors are Ca
2+-permeable nonselective cation channels, this
effect on ICC activity is presumably through enhancement of Ca
2+
influx from the extracellular space, through itself and simultaneous
activation of voltage-gated Ca
2+-permeable channels. ICC appear
to be a promising target in functional motility disorders in the gut.
Supporting Information
Figure S1 An example of 5-HT-augmentation of ICC pace-
maker [Ca
2+]i oscillations in an ileal musculature preparation. Ileal
musculature segments (,5m m 620 mm) containing the myenter-
ic plexus, the same preparation used in 868 MEA measurements,
were loaded with Fluo-3AM. Fluo-3 emission light images were
continuously monitored the same as cell cluster experiments. The
extracellular solution contained 1 mM nifedipine and 250 nM
TTX. A) A control fluorescent image. B and C) Series of ratio
images of a [Ca
2+]i oscillation cycle in control and in the presence
of 5-HT (10 mM), respectively. Each image was acquired at
300 ms intervals. Video S1 and Video S2 correspond to ratio
images shown in B and C, respectively. Note that green represents
the Ft/F0 ratio of ,1 in cell cluster preparations (Fig. 1A) to
Figure 6. Potentiation of ICC electrical activity with 5-HT
(10 mM) and 2-Me-5-HT (10 mM). All measurements were carried out
in the presence of nifedipine (1 mM) and TTX (250 nM).
doi:10.1371/journal.pone.0024928.g006
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of ,1 in musculature preparations, because the size of
preparations were larger than the frame of the image. After 5-
HT application the active area markedly increased.
(TIF)
Figure S2 Regular occurrence of pacemaker [Ca
2+]i oscillations
after application of 5-HT. A) Ca
2+ images acquired from a cell
cluster preparation in control (a–c) and 5 min after 5-HT (10 mM)
application (d, e). This preparation showed intermittent [Ca
2+]i
oscillations in control condition. B) Time course of pacemaker
[Ca
2+]i activity recorded in the square (x) indicated in A: control
(left) and 5 min after application of 10 mM 5-HT (right). Dotted
lines correspond to the times when images (a–e) were acquired. C–
E) Bar graphs showing changes in the peak amplitude (C),
frequency (D), and active area (E) of spontaneous pacemaker
[Ca
2+]i activity (Mean 6 S.D., n=6).
(TIF)
Figure S3 An example of the effect of 2-Me-5-HT (10 mM) on
field potentials. Field potential images in control (A) and during
application of 2-Me-5-HT (B) are displayed at 200 ms intervals.
Note, 2-Me-5-HT-enhanced ICC electrical activity, as seen during
5-HT application.
(TIF)
Figure S4 Possible underlying mechanisms for 5-HT-enhance-
ment of gut pacemaker activity and contractility. It is thought that
intracellular Ca
2+ release channels, i.e. ryanodine receptors (RyR)
and InsP3 receptors (IP3R) in ICC are periodically activated by the
support of a Ca
2+ influx pathway across the plasma membrane,
although mechanisms underlying the coordinated actions of
intracellular and plasma membrane ion channels are not yet
known. 5-HT augments ICC [Ca
2+]i oscillations presumably (1) by
facilitating Ca
2+ influx via 5-HT3 receptors, and (2) simultaneous
activation of voltage-gated Ca
2+-permeable insensitive to DHP
Ca
2+ antagonists (DHP(-)VGCC). In ICC, [Ca
2+]i oscillations
periodically activate Ca
2+-activated ion channels in the plasma-
membrane, i.e. Ca
2+-activated Cl
2 channels (ClCa) and/or Ca
2+-
activated nonselective cation channels (NSCCCa), and thereby
generate electric pacemaker activity. In smooth muscle (SM) cells,
conducted pacemaker activity via gap junction (GJ) channels
activates DHP-sensitive voltage-gated Ca
2+ channels
(DHP(+)VGCC), i.e. L-type Ca
2+ channels, causing periodic
contraction. In the present study, to differentiate ICC activity,
all experiments were carried out in the presence of a DHP Ca
2+
antagonist, nifedipine.
(TIF)
Video S1 [Ca
2+]i oscillations measured in a musculature
preparation in normal condition, corresponding to Figure S1B.
(MPG)
Video S2 [Ca
2+]i oscillations measured in a musculature
preparation in the presence of 5-HT (10 mM), corresponding to
Figure S1C.
(MPG)
Video S3 Field potential oscillations acquired under a control
condition, corresponding to Figure 5A. An 868 microelectrode
array with a polar distance of 150 mm was used. The recording
area was ,1m m
2.
(MPG)
Video S4 Field potential oscillations acquired 5 min after
application of 10 mM 5-HT corresponding to Figure 5B.
(MPG)
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